Systems and methods of health care product delivery

FIELD: medicine.

SUBSTANCE: methods describe the stages of over-the-counter, limited health care product delivery by an automatic slot machine located in points of general sale. The products are delivered by at least identifying the buyer's biometric data, as well as by auto select and/or deselection criteria. Systems contain an automatic slot machine connected with a controller provided to identify the buyer's access rights to the selected health care products.

EFFECT: enhancement ensured by providing the patient's access to the health care products by the automatic slot machine, and higher reliability ensured by identifying persons receiving the health care products.

36 cl, 17 dwg

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims the priority of provisional application No. 61/002,360, filed in the U.S. on November 8, 2007, and provisional application No. 61/068,909, filed in the U.S. on March 11, 2008, the entire content of which is incorporated into the present application by reference.

The prior art INVENTIONS

1. The technical field of the invention

The present invention relates to systems and methods for issuing medicines, nutraceuticals and medical devices (hereinafter collectively the "medical products"). In particular, the present invention relates to systems and methods for issuing medical products from the vending machine using the algorithm of the automatic selection and, in some embodiments, implementation of the algorithm deselect that eliminates the need for interaction of the customer with the licensed practical doctor. In addition, the present invention relates to a method of securing a tool of risk management for transfer of prescription medical products to OTC status, freely available. In addition, the present invention relates to systems and methods that provide greater access to freely available medical products subject to sales restrictions or the reference is to soobrajeniam public safety and/or public health.

2. An overview of the state of the art

Medicines, vaccines, biological products and pharmaceutical preparations (hereinafter individually and collectively the "drugs") are usually used for the treatment, therapy and/or ameliorate a variety of disorders and diseases of humans and animals. With the issuance of the aforementioned products in the USA medicines, in General, are divided according to article 503(b)(1) of the law on food, drugs and cosmetics into two classification groups, namely the classification of the group of prescription and classification group OTC. In particular, the Management of sanitary supervision of food and drug administration (FDA) requires a prescription for the issuance of any drug that is unsafe for use otherwise than under the supervision of a practitioner licensed by law to use medicines. Therefore, FDA may designate drug OTC status, if the FDA determines that the vacation a prescription is not required to protect the public health by reason of the toxicity of drugs or other potential harmful effect, or the method of its application, or additional measures necessary to its use, and the drug is safe and effective deprimente for self-medication, prescribed on the label.

Due to the strict regulation of medicines in the classification group of prescription medications mentioned prescription drugs are mainly licensed pharmacies. Usually medicines are controlled and stored indoors pharmacies, namely in the restricted division (literally, "behind the counter") pharmacies to issuance of medicines from the pharmacy could be exercised only by the pharmacist (hereinafter referred to as "licensed practical doctor"), or under his supervision.

In the opposite case, when the actual data, which require the adoption of appropriate organizational and technical measures and marks in a given place for the safe and effective application in the conditions of free access, prescription medications, usually translated freely available in the room (OTC) from the premises of the limited sales and premises total sales in the pharmacy or other retail total sales. In the context of this application the term the premises or place "total sales" shall mean any location where access to the drug is not limited. Essentially, premises or place overall sales may contain spaces inside the store, but not limited to available the service pharmacies or partially available to the Department of trade terminal, and may include areas outside of the store.

In addition to the rules imposed on drug organization FDA, the treatment of certain drugs is limited or regulated by at least one Agency of the Federal government or the state government, such as Ministry of justice (DOJ), the Administration for the enforcement of the law enforcement (DEA) or Pharmaceutical departments of the individual States.

For example, pseudoephedrine (PSE) is a medicine that has the status of over-the-counter and is commonly used as a decongestant. However, the PSE may also be used in the production of Smoking and illegal drugs, for example, but without limitation, methamphetamine. Essentially, government agencies are required to wholesalers or retailers PSE and PSE-containing products that are regulated by the state, regulated, or restricted circulation of PSE and PSE-containing products. The limit for PSE and PSE-containing products usually involves the relocation of the mentioned products in limited available the Department to track the sales of the mentioned products. Approval for documenting sales information and information about the buyer is usually performed in the terminal. Accordingly, although the PSE is OTC drug among the STV, which, otherwise, were exhibited for sale in a freely accessible position, statement of other organs and restrict circulation related to the sale of the mentioned tools, ordered retail organizations place mentioned drug in limited available the Department to collect information on compliance. Therefore, public authorities have the right to determine the rules of any freely available drug and translate the mentioned medicines in limited available the Department for reasons of public health.

Recently some medicines classified in the USA as a medication with dual status. Drugs with dual status are drugs that belong to the classification group OTC for some parts of the population, but remain in the classroom prescription for other parts of the population. For example, emergency oral contraception Plan-B can be issued without a prescription to women over the age of 18 years, but women under the age of 18 years shall be issued only by prescription. Accordingly, other medicines, such as the aforementioned oral contraceptives are classified as prescription and over-the-counter. The mentioned drugs with dual status d is accessible only in limited available Department of pharmacy, as before OTC vacation, licensed practical doctor should check compliance with certain criteria, for example to check the age.

Most States regulate the circulation of medicines like the above instructions for the circulation of medicines in the United States.

For example, Australia uses a system of circulation of medicines, which classifies accessible system of treatment in four different categories or lists, namely A (Unregulated), Schedule 4 (4), Schedule 3 (list 3) or Schedule 2 (list 2). It should be noted that the term list in the Australian classification system does not coincide with a similar term used in the US and referred to in paragraph 812 U.S.C. (United States Code) and the Law on control of drugs and medicines.

In Australia an ad hoc list of medicines are products for General sale, which are available without a prescription or interaction with the pharmacist and, therefore, usually is publicly available in any retail establishment. In contrast, drugs that are classified in the list 4 and list 3, are partially accessible to the Department and classified on list 2 are freely available in the Department of pharmacy. In particular, the medicinal product, the class is Vicereine as "drug list 4", available only by prescription and are available for distribution from the limited available Department through pharmacist in the pharmacy. Drugs classified as "drugs on the list of 3 available without a prescription (i.e. as over-the-counter medicines), but can only be dispensed by a pharmacist in the pharmacy. Therefore, the drugs on the list of 3 available for distribution from the limited available Department to provide the necessary interaction between pharmacist and patient. Drugs classified as "drug list 2", available without prescription, but may need to consult a pharmacist before it is issued. Essentially, medicines list 2 also place for sales and access freely available in the Department, but with the possibility of interaction between the pharmacist and the patient and only in the drugstore.

In another example, in the UK applies the system of circulation of medicines, according to the classification to which the drug belongs to one of three categories, namely for total sales, sales through pharmacies and prescription sales. As the name implies, medicines for total sales available without a prescription and do not require any interaction with the pharmacist and, therefore, available in free is the bottom affordable, the Department premises total sales retail outlets. Sale through pharmacies without a prescription, but provide a means to communicate with the pharmacist and, therefore, are partially accessible through the Department of pharmacy. In addition, the sale by prescription only possible when prescribed and, therefore, are only partially accessible through the Department of pharmacy.

As follows from the above, the circulation of medicines are usually based on the classification system that, as a rule, is a consequence of the presence of drugs or available without restriction treatment available, which does not require interaction with the doctor or pharmacist, either in stock with sales restrictions partially accessible through the Department, when required interaction with a pharmacist or another employee.

In the present invention found that the difference between drugs available with restrictions from restricted Department" (literally, "over the counter"), and drugs that are available with restrictions or without them, "freely available, the Department is essential for retail or wholesale trade in medicinal products. In particular, the "freely available" medicines are not subject to the restrictions do not require the licensed to the pharmacies or any interactions with the employee or pharmacist when you purchase by the buyer. On the contrary, "partially accessible" drugs and "free" drugs, which are subject to age restrictions, requiring interaction with an employee at purchase by the buyer.

In addition to regulations applicable to medicines, described in detail above, there are also rules governing the treatment of many medical devices, such as, but without limitation, needles for subcutaneous injections, HIV tests, some of orthopedic devices. For example, in many States, the sales needle for subcutaneous injection requires a prescription and/or to individuals who have reached a pre-determined age. In addition, some medical devices are available only with a prescription. Therefore, access to many non-drug medical devices is complicated by limitations on appeal, the same algorithm.

In addition, many products are related to a more General class of products referred to in this application as "nutraceuticals"which contains such products as, for example, but without limitation, food additives, food products with functional additives, dietary supplements, vitamins, medicines from plant materials, medical foods and other. It is assumed that at least one of the above is the aforementioned and other nutraceuticals may have the status of limited circulation, assigned to the regulatory authority, manufacturer, retail trade organization and any of its associations.

Furthermore, the distinction between medical products sold through the "restricted section", and medical products sold through "freely available to the Department, it is important for consumers who intend to apply or to choose some medical products. For example, freely available medical products that do not require interaction with an employee, a medical products more convenient for the consumer.

Accordingly, in the present invention found that there is an urgent need for systems and methods of issuing medical products, having the status of over-the-counter, without the need for additional prohibitions and restrictions normally associated with these sales only of limited available departments and through pharmacies. In addition, in the present invention found that there is a need in the ways of translation of prescription medical products to OTC status using electronic vending machine as a means of support, assistance and access restrictions to ensure safe and effective application referred to prescription products freely available in the Department.

In addition, nastojashem the invention installed, what is an urgent need for systems and methods of issuing medicines, having the status of over-the-counter, without the need for additional prohibitions and restrictions of access exists in the retail trade organizations that use physical barriers or have a medical products and devices in a limited available the Department or under the supervision of sales staff to restrict access to prevent theft.

The INVENTION

The present invention provides methods and devices for issuing OTC, limited available medical products (i.e. medicines, nutraceuticals and medical devices) using a vending machine in combination with an electronic automatic selection.

The present invention also provides methods of issuing OTC, limited available medical products from the vending machine in a place of total sales using a vending machine in conjunction with procedures such as selection and deselect.

In some embodiments, the implementation of the present invention provides methods for issuing OTC, limited available medical products from the vending machine in a place of total sales using the stage to automatically select, based at least in part, on b the metric data. Biometric data can be locally entered by the buyer (manually or supplied biometric measuring device) or caused by a vending machine from a reference laboratory or other external source.

In some embodiments, the implementation of the present invention provides systems and methods of transfer of prescription medical products to OTC status, freely available. In the case of systems and methods in accordance with the present invention provide an interactive consultation with additional measures necessary to meet the requirements established by the organization by the FDA for the translation referred to in prescription medications.

We propose a method of issuing medical products limited circulation. The method includes a step of identifying a particular medical product, having the status of a limited circulation; the installation phase of the vending machine in a place of total sales, while the vending machine includes a user interface associated with the controller; a step of preserving the stock of a particular medical product in a vending machine; a step of preserving electronic procedure to automatically select a controller; and a stage control a vending machine by the controller, for producing the first product unit specific copper is Ty product only when if the buyer successfully performs the automatic choice for the initial request to purchase a particular medical product through the user interface.

It is also proposed a method of giving over-the-counter, limited available medical products from the vending machine in a place of total sales. The method comprises a stage of acceptance of a purchase request from the buyer at the vending machine on a particular over-the-counter, limited available medical product; a step of determining whether the request is for the purchase of an initial request or a subsequent request of the buyer for the purchase of a particular medical product; stage call automatic algorithm selection for the particular medical product if a purchase request is the initial request for purchase; stage call algorithm deselect a specific medicinal product, if a purchase request is a subsequent request for the purchase; the stage of submission of the buyer requirements to enter a response to each of the many questions generated by the algorithm for automatic selection or cancellation algorithm choice; and the stage management of a vending machine by automatic algorithm selection or cancellation algorithm of choice to give or not to issue a particular medical product based on the answers.

In kotoryj variants of implementation proposed method of issuing a medical product from the vending machine in a place of total sales. The method comprises a stage of acceptance in a vending machine of a purchase request from a buyer for a particular medical product; stage call algorithm issuance for the particular medical product; the stage of submission of the buyer requirements to enter a response to each of the many questions generated by the algorithm of issuance; the stage of collection of biometric data from the customer; and the stage of determination to issue or not a particular medical product based on the answers and based at least in part, the biometric data.

The system of issuing medical products, which contains a vending machine, at least one device user interface and a controller associated with a vending machine and at least one device user interface. Vending machine limits the storage location that can accommodate at least one medical product limited treatment and at least one medical product unrestricted circulation. The system further comprises an algorithm for automatic selection, permanently stored in the controller, for each of the medical products limited circulation in the place of storage. The controller is configured to determine, after selecting a specific medical product limited treatment available is elem through, at least one device user interface, whether the choice of a particular medical product limited treatment of the first query or the second or subsequent request for a particular medical product limited circulation. The controller makes the buyer a request to perform an algorithm for automatic selection, if the request is the first request. The controller provides specific medical product limited circulation only if the buyer successfully executes the automatic algorithm selection.

Offers a way to market a medical product, which contains the following steps: provide a controller that contains the selection algorithm is constantly stored in the controller; give the customer the opportunity to call the algorithm selection; control algorithm selection to provide to the buyer a multitude of exemplary symptoms or disease States through at least one input device and the communication device, a visual or acoustic type; give the customer the opportunity to choose at least one symptom or condition of a disease from a variety of exemplary symptoms or disease States, when at least one symptom of a condition or disease consistent with those in the present time experiencing the buyer; and control algorithm p is dbora, to provide a list of at least one appropriate medical product against at least one of the selected symptom or condition of the disease.

Offers a way to market a medical product, which contains the following steps: storing electronic automatic selection relating to the medical product, in the controller; storing electronic procedure deselect related to the medical product, in the controller; provide a potential buyer of a medical product to cause the electronic procedure to automatically select and deselect; control the controller via e-automatic procedure of choice to ensure recording of transactions for medical product only if the potential buyer successfully performs the automatic choice for the initial request for the purchase of medical product; and control the controller via e procedure deselect to to ensure recording of transactions for medical product only if the potential purchaser successfully completes the procedure to cancel a selection, for the second or subsequent request for the purchase of medical products.

The above and other features and advantages of the present invention will become about evenini and understandable to experts in the art from the following detailed description, the drawings and the accompanying claims.

A BRIEF DESCRIPTION of SEVERAL VIEWS of DRAWINGS

Figure 1 - diagram illustrating a sample implementation of the system of issuing medical products in accordance with the present invention;

Figure 2 is a visual explanation of various classes of medical products, which is supposed to be possible to use with the system of issuing shown in figure 1;

Figure 3 - way issue of medical products in accordance with an exemplary embodiment of the present invention;

4 is an alternative exemplary variant of the method of issuing medical products in accordance with the present invention;

5 is another alternative exemplary variant of the method of issuing medical products in accordance with the present invention;

6 is an exemplary variant of the method of translation is limited available, prescription medical products in the category freely available over-the-counter medical products using the vending machine in accordance with the present invention;

7 is an alternative exemplary variant of the method shown in Fig.6;

Fig(a)-8(g) - alternative a sample implementation of automatic algorithm selection and algorithm deselect; and

Fig.9-11 diagrams illustrating alternative exemplary embodiments of the system of issuing medical products in accordance with the present invention.

DETAILED description of the INVENTION

In the drawings, and particularly figure 1 depicts a sample implementation of the system 10 issue of medical products. In a preferred embodiment, the system 10 is configured to issue medical products subject to restricted circulation, without binding interactions between the customer/user/consumer (hereinafter referred to as buyer) and licensed practical doctor or another member of the sales.

It should be understood that the buyer of medical products may or may not be a user of medical products. For example, the present invention provides for the purchase by the parent or other guardian medical products for a child or other dependent. However, for clarity, the present invention should be described on the example in which the buyer and the user are one and the same person. Therefore, the user of the system 10, the user of medical products and the buyer are for clarity in the present description one and the same person.

The system 10 provides the buyer with effective leadership using the sequence of questions related to medical history and medical products, and also provides the buyer with interest and the value of information about a particular product./p>

Thus, the system 10 provides an electronic device instead of a well-informed broker (i.e. a licensed practitioner) by collecting critical parts, which provides a well-informed broker, and also provides more effective methods for safe and effective use of prescription or limited available medical products in terms of free sales.

In particular, the system 10 provides an interactive vending machine with computer control, with access to the system recognizing a buyer, a specialized product algorithm 24 to automatically select and, in some embodiments, implementation, specialized product algorithm 26 deselect any medical product. The system 10 produces a medical product selected by the buyer, if the buyer meets the conditions for a medical product. In the example in which the medical product is limited to an appeal on the basis of labels or product specifications governmental body, the system 10 according to the denition of algorithm 24 is automatically selected in accordance with the information entered by the buyer, determines whether the buyer conditions on medical product. After subsequent requests for specific is medicinski product system 10 may issue a subsequent product specific medical product, if the buyer remains with the relevant conditions for a medical product that is determined by the algorithm 26 deselect in accordance with the previous and new information entered by the buyer, or limitations specified by the label or other government agencies.

In an exemplary embodiment of the present invention, the system 10 includes a vending machine 12, containing at least one device 14 man-machine interface. The system 10 also includes a controller 16 that is associated with a vending machine 12 and interface device 14. Vending machine 12 limits the 18 storage, configured to accommodate therein at least one different medical product 20.

Figure 2 shows the different categories of medical products 20 that are anticipated for use with the system of issuing shown in figure 1. For example, the system 10 can be used for the marketing of some freely sold over-the-counter medical products 20a, which can be sold without any restrictions treatment imposed by a regulatory body (e.g., FDA, DEA) or other relevant competent regulatory organization. In this case, the system 10 may sell medical products 20a without the need for algorithms 24, 26. For example, medical products 20a soda can in order to avoid such products, to which access is restricted due to theft or natural attrition. In addition, in the present invention it is assumed that the retailer and/or manufacturer of the product must impose restrictions on the use of at least one medical product 20a, which differ (for example, may be more restrictive) of the limitations that required the aforementioned regulatory bodies/organizations. In these examples, the retailer and/or manufacturer may choose to apply the algorithms 24, 26 in the marketing of various medical products 20a.

In addition, the system 10 can be used for other sales of medical products, 20b, 20c and 20d, which are characterized by at least one constraint handling.

Therefore, the system 10 can be used for the marketing of some freely-available, over-the-counter medical products 20b (e.g., PSE-containing products and the like), which can be sold only after checking at least one of characteristics such as the age of the buyer. In the present invention it is also assumed that the system 10 should be improved to include other freely available over-the-counter medical products 20b, which can later be edited in limited sold.

The system 10 distributes medical products 20b be the needs in the algorithm 26 deselect, and instead uses an algorithm 24 of choice, which requires checking only the date of birth or age, and, in some cases, the number of purchases of a particular medical product 20b within a predefined period of time. In this embodiment, the system 10 may be configured to memorize or store the information about the purchase in the controller 16. Because the controller 16 is, in some embodiments, implementation, common to several retail places, the system 10 is configured to automatically control purchases from different places of storage of medical products 20b limited treatment (e.g., PSE-containing products). The system 10 can prevent the sales of these medical products limited treatment on the basis of admissible purchase quantities, despite the fact that the information about the buyer (e.g., age) meets the required limits.

The system 10 can be used to support or provide additional methods that allow the marketing of certain limited available over-the-counter medical products 20c, such as the aforementioned drugs with dual status, drugs, classified according to the list 4 and list 3 in Australia, and pharmacy sales in the UK.

In addition, the system is mu 10 can be used to support or provide additional ways allow the marketing of certain limited available, prescription medical products 20d that meet or can be made to satisfy the requirements for "translation" from prescription status to OTC status. In addition, the system 10 can be used to support or provide additional methods that allow the marketing of certain limited available over-the-counter medical products 20c that meet or can be made to satisfy the requirements for "translation" from status to be restricted to the status freely available.

During the marketing of medical products, 20c, 20d, the system 10 provides a means algorithm 24, 26 interactive device to agree to additional measures that, for example, provides approval with labeling requirements and, therefore, provides the confidence needed for translation of medical products from prescription status to OTC status and/or status partially accessible status freely available.

Accordingly, in the context of this application, the term "medical products limited cases covers at least one of the products 20b, 20c and 20d.

As also shown in figure 1, the interface device 14 may be a device 14-1 any type of data entry and communication, for example, but without whom ograniczenia, the screen of the video display, a standard alphanumeric keyboard, mouse, or pointing device, a touch screen, a reader with credit cards, bar code reader, speaker, microphone, voice recognition, printer, port wired communication port for wireless communication and any combination thereof. Thus, the buyer, using the vending machine 12 can enter personal information, when necessary, for example, name, address, and information about health insurance, age, and past history of disease, information is freely available or prescription drug, billing information and any other information requested by the controller 16 and used algorithms 24, 26 to determine whether to sell a medical product 20 to the buyer.

When the vending machine 12 is not used in the work, the system 10 controls the device 14-1 data entry and communication by the controller 16 to provide verbal and/or visual medical information to people near the vending machine. The device 14-1 data entry and communication can be physically built into the vending machine 12, or may be electrically connected with a vending machine.

In other embodiments, implementation, and as more is explained in the following description, the interface device 14 can the t also contain, at least one device 14-2 identifying at least one device 14-3 collection of biometric data, at least one payment device 14-4 (shown only one device), and combinations thereof.

In its simplest form, the identity of the purchaser can be sure the manual input by the user identification information through the device 14-1 data entry and communication. In other embodiments, implementation of, or in addition to the variant implementation, the system 10 may include a device 14-2 identification, which is any device, usually used for electronic identity verification individual buyer. For example, the device 14-2 identification may be a device for reading magnetic stripes or bar code reader, which accepts information from an identification card such as driver's license, health insurance or medical history and medical diagnostic card, if such technology is developed, credit cards and other. In other embodiments, the exercise device 14-2 identification may contain more complex device identification, for example, but without limitation, the device fingerprint scanning device scanning, iris recognition, face recognition device, the device is in scan DNA, and combinations thereof.

The device 14-3 collection of biometric data is integrated into the vending machine 12 and is arranged to measure at least one biometric characteristic of the customer for use by the system 10 in algorithm 24 to automatically select and, if necessary, the algorithm 26 deselect. For example, the device 14-3 collection of biometric data may be a device such as, for example, but without limitation, a blood pressure monitor or monitor blood glucose, so that the system 10 could collect readings of blood pressure or glucose readings from the device.

In the context of the present invention, the terms "biometric data" and "biometrics" apply equally important and must work together to indicate the measured data characterizing at least one physiological condition of the buyer. Referred to as ' biometric information and biometric characteristics can be measured by direct contact with the buyer, using, for example, a cuff for measuring blood pressure, thermometer, infrared analyzer, acid-base balance of the blood and other Biometric data and biometric characteristics can also be measured by taking measurements on the buyer, such as height, weight, whole blood, serum, saliva, urine, feces, and any of them is combinaci. In addition, biometric data and biometric characteristics" can include any clinically measurable quantity, normally get licensed practical doctor during physical examination ordered as part of a formal laboratory analysis.

It should be understood that in the description of the present invention, the device 14-3 collection of biometric data are only shown for example in the form of data collection devices blood pressure and blood glucose. Of course, in the present invention, it is assumed that the device 14-3 collection of biometric data must collect any biometric data of the customer, for example, but without limitation, the body temperature of the buyer, the blood sugar level, cholesterol level in the form of low density lipoprotein (LDL)cholesterol in the form of high density lipoprotein (HDL), total cholesterol, triglyceride level, the degree of oxygen saturation of the blood, heart rate, blood pressure, body temperature, lung function parameters (i.e. the volume of air in forced expiratory per unit time) or any other information about the lungs, cardiovascular system, blood, and urine chemical analysis chair available licensed practical doctor.

It should also be understood that the vending machine 12 n is limited by the input biometric data through the device 14-3 collection of biometric data. In the present invention is provided, instead of the aforementioned equipment to vending machine 12 allowed the collection of biometric data in a variety of ways, of which the device 14-3 collection allows the direct measurement of the vending machine.

In some embodiments, the exercise of buyer can enter biometric data through the device 14-1 data entry and communication. For example, the buyer may enter from the keyboard reading blood pressure or cholesterol vending machine 12 through the device 14-1 data entry and communication. Alternatively, the buyer may present a diagnostic map 30 map or history of disease in the device 14-1 data input to the input device has scanned or read information from cards, including biometric data, if available, in the vending machine.

Alternatively, the buyer can connect the device biometric measurements submitted by the buyer (not shown)for electrical connection with a vending machine 12 through devices 14-1 data entry and communication, in examples in which the input device is a communication port. Thus, the buyer can connect customer supplied device, such as device control blood glucose, the vending machine 12 and load or transfer, what about the least one private value to the system 10.

In another implementation options the buyer can enter biometric data through the device 14-1 data entry and communication using input devices to allow the controller 16 to receive biometric data from the external diagnostic or laboratory center 28. For example, before pairing with a vending machine 12, the buyer may be the diagnosis in accordance with at least one Protocol in the external diagnostic center 28. The results of the above diagnostic protocols are stored in the database 30 data associated with the external diagnostic or laboratory center 28. In the present case, the buyer may allow the vending machine 12 to cause the results stored in the database 30 data over a network connection such as the Internet.

The payment device 14-4, if necessary, may accept payment of at least one type. For example, the payment device 14-4 may be the reader's credit card or debit card can be a device receiving paper money or coins, and any combinations thereof. In some embodiments, the implementation of the vending machine 12 may be defined through the controller 16 the cost of purchasing medical product 20 on the basis of information on the insurance provider, enter the th buyer.

Vending machine 12 and/or the controller 16 may be configured to control 18 storage for storing medical product 20 at ambient conditions of storage, air-conditioned storage conditions or any of their combinations. In the context of this application the term ambient storage conditions should mean that the medical product 20 are light, storage temperature and humidity when stored within designated 18, which are external relative to the location in which the machine 12. On the contrary, the concept of air-conditioned storage conditions should mean that in 18 of the regulation to satisfy the recommended conditions of storage of medical product 20 through regulation or conditioning at least one of the degree of lighting, storage temperature permissible humidity during storage and any combinations thereof.

In addition, it is assumed that the vending machine 12 can contain many seats 18 for storage, of which some places are regulated to ambient conditions of storage allowed for medical product 20 contained therein, and other places provide adjustable storage conditions allowed for medical product 20 contained therein.

Thus, the vending machine 12 may be the ü performed, if necessary, with the ability to store any required medical product 20 within the place or places 18.

It should be understood that the vending machine 12 described above, which is limited to, at least one seat 18 storage inside the vending machine. However, in the present invention it is assumed that the space 18 may be an auxiliary device 18-1 of storage that is physically associated with and/or otherwise managed by a vending machine 12 and/or controller 16. For example, in the present invention it is assumed that the space 18 may be formed in the Cabinet for supply of drugs, with drawers, for example, those that are sold to hospitals.

Medical product 20 can store or keep in a container in a form selected commodity units appropriate for a particular drug and condition of the subject treated. In some examples, the size of the selected item may be subject to the requirements of the FDA or other governmental body. For example, the medical device 20 can be stored in the form of commercial units containing tridtsatiletnii medical supply product.

In one embodiment, vending machine 12 includes at least one sensor (not shown)associated with the controller 16. The system 10 may kontrolirovat the domestic supply of medical products 20 in the seat 18 and to inform the supplier or retailer, when padding is needed.

In the above embodiment, system 10, the controller 16 shown remote from the vending machine 12 and exchanging data with it over the network 22. However, in the present invention, it is assumed that the controller 16 may be in the vending machine 12. In addition, it is assumed that the system 10 may include two controllers, one located in the vending machine 12, and one remote from the vending machine, with both controllers communicate over the network 22. The network 22 may be any desired communication network, for example, but without limitation, a distributed network, the Internet and other networks.

The system 10 includes an algorithm 24 to automatically select and, in some embodiments, the implementation, the algorithm 26 deselect located in the controller 16. In one embodiment, the controller 16 and, therefore, algorithms 24, 26 are located in a Central location and are electrically connected with many vending machines 12. In other embodiments, implementation of the controller 16 and, therefore, algorithms 24, 26 are in the same vending machine 12. In this case, the algorithms 24, 26 are automatically updated from a remote Central premises, if necessary.

When using the system 10, the buyer requests the purchase of a particular medical product 20, stored in the shopping car is at the 12, through the device 14 input. In response to a purchase request, the controller 16 can control the vending machine 12 to request the buyer to enter specific personal information of a General nature describing a buyer, for example, but without limitation, the name, age, address, social security number, past medical history, current medication use in the past by a particular medical product, etc. of Course, in the present invention it is assumed that the vending machine may not require the purchaser of the introduction of any personal information.

Taking into account the specific requested medical product 20 and, if necessary, the personal information of a General nature, the controller 16 determines whether the request is for the purchase of initial or subsequent request of the buyer for the purchase of a particular medical product 20. In other variants of implementation, in which personal information is absent, the controller 16 may request the buyer whether the request is for the purchase of initial or subsequent request of the buyer on a specific medical product 20. If the request is an initial request, the controller 16 executes the algorithm 24 automatic selection. However, if the request is not an initial request, and the second or subsequent request, the controller 16 performs Sal the rhythm 26 cancel the selection.

In a broad sense, the algorithm 24 automatic selection determines whether the right of the buyer to use the medical product 20, and the algorithm 26 deselect determines whether the buyer is entitled to medical product.

In the context of this application, the term "automatic selection" means the procedure for the use by the buyer of a specialized product algorithm, which reflects the critical issues and information, established by government authority and contained on the product label, and then helps the buyer or instructs him on how to choose or to apply or not a specific product based on the information listed on the product label, taking into account personal history of diseases of the buyer, demographic data and signs and symptoms of the disease state to be treated. The procedure of automatic selection provides analysis by type of risk-benefit at the time of original purchase, so benefit from the start of treatment outweighed the risks associated with failure from the start of treatment or seeking medical advice.

In the context of this application, the term "clear" means the process by which a buyer who has already started therapy specific product, again reviewed the critical details and information (e.g., warnings, precautions pregesterone the tee and instructions) approved labels, as well as your current medical history to make a determination about whether to continue or discontinue use of the product. Procedure deselect may also contain the same or different issues of special interest that have been listed in the procedure of automatic selection. Procedure deselect provides analysis by type of risk-benefit each time a buyer makes an attempt to re-buy a specific product to benefit from further treatment outweighed the risks associated with continued treatment. In addition, the procedure deselect automatically limit the duration of therapy until a predefined duration, for example, by controlling the number of requests for a particular medical product made by a particular user.

Algorithm 24 selection is composed with the possibility of arming the many issues before the buyer through the device 14-1 data entry and communication based on the approved label of the medical product 20 requested by the buyer. In some cases, many questions may contain familiarize the buyer with specific warnings or other critical information. Answers the buyer's questions are entered through devices 14-1, 14-2 and 14-3, on demand. In response to the answers a buyer algorithm 24 SEL the RA determines, whether the buyer is entitled to specific requested medical product 20.

Algorithm 26 deselect developed with the possibility of arming the many issues before the buyer through the device 14-1 data entry and communication with the accounting requested by the buyer medical product 20 and the past use of the system 10. And again, in some cases, many questions may contain familiarize the buyer with specific warnings or other critical information. Answers the buyer's questions are entered through devices 14-1, 14-2 and 14-3, on demand. In response to the answers a buyer algorithm 26 deselect determines whether the buyer the right to continue the use of certain requested medical product.

Thus, the system 10 limits the access to medical product 20, when the information of the buyer and the past use of the system 10 for the same drug or device, installed algorithms 24, 26, do not meet the necessary conditions, the label or restrictions for select medical product. For example, the wrong answers to the questions posed algorithms 24, 26, cause the controller 16 does not allow the issuance of a medical product 20 of the vending machine 12.

The system 10 provides controlled by the patient system, RA is put in the terminal, which determines the identity of the patient, shall accept the first and subsequent requests for the purchase of specific medical product 20, uses algorithms 24, 26 to determine whether the right patient to the receipt or continued receipt of the respective medical product provides the customer warning information, and information about safety precautions in respect of a medicinal product through the device 14-1 data entry and communication, speech, visual and/or printed form, analyzes and calculates requirements for the limitation or compliance specified on the approved label or set by government agencies, and executes the sale and purchase via the payment device 14-4, if you want, and gives out medical product in the proper case.

In a preferred embodiment, the system 10 ensures accuracy and compliance with the selection criteria laid down in the algorithms 24, 26, and approved the label provides important educational training of the purchaser prior to and during use, provides full access to retail medical product 20 having the status of a limited circulation (i.e. products, 20b, 20c and 20d), handles the operations of purchase and sale in the vending machine 12, checks that the state of the disease still exists, when queried after the respective purchase documents and stores in the memory information of the patient, causes the information and is the cause of failure or need medical advice, documents and stores sales information (e.g., PSE), without the obligatory participation of a pharmacist or another employee retail sales. Thus, the system 10 can be used for medical products limited recourse subordinated FDA/DEA/state agencies (e.g., PSE-containing products, drugs with dual status, and so on), as well as for the global schema restrictive measures in respect of restricted drugs.

Thus, the system 10 is applicable for transfer OTC, limited available medical product in the category medical product for General sale, without requiring the intervention of a licensed practitioner. The system 10 is applicable as authorized tool of risk management and an additional way of ensuring the possibility of transfer of prescription medical product in the OTC category, freely available or free selling a medical product. In addition, the system 10 is applicable as authorized tool of risk management and an additional way of ensuring translation features high waist color noble is zeptomole, limited available medical product in the category of freely available or free selling a medical product.

If the system 10 determines, with the help of algorithms 24, 26 to automatically select or deselect that the buyer is entitled to choose the particular medical product 20, the system manages the vending machine 12 so as not to produce a medical product 20. In some embodiments, the implementation of the system 10 may provide instructions, guidance and/or recommendation to the buyer through the device 14-1 data entry and communication, in relation to the steps required to obtain a specific medical product. For example, system 10 may provide a written statement, visually observable instructions, verbal instructions and any combination of them (through the device 14-1 data entry and communication).

Next, figure 3 presents the method outlined in General position 40, to transfer OTC partly available or freely available medical product, subject to the limitations of the treatment, in category medical product for General sale.

The method 40 includes a step 42 of the identification of the specific restricted or freely available medical product covered by at least one restriction treatment (20b, 20c) and ogliastro translation and the stage 44 installation of the vending machine 12 on the place of total sales. As explained above for Figure 1, the vending machine 12 includes a front-end device 14 associated with the controller 16.

The method 40 includes a step 46 the conservation reserve medical products in a vending machine and stage 48 preservation of electronic procedures 24 of choice in the controller 16. Then the method 40 includes a step 50 control a vending machine by the controller for the grant of the first commercial unit of the particular medical product only if the buyer is identified and successfully performs the automatic selection is based on either the approved requirements, labels, or other governmental restrictions relating to the original request for the purchase of a particular medical product, via the interface device 14.

In some embodiments, the implementation of the method 40 further comprises the step 52 preservation of electronic procedures 26 deselect the controller 16. Finally, the method 40 includes a step 54 control a vending machine by the controller to issue a second or subsequent trademark of units of a particular medical product only if the buyer successfully executes the procedure deselect and meets approved requirements labels or other government limited the tion, related to the second or subsequent request for the purchase of a particular medical product, via the interface device 14.

In other embodiments, implementation of the method 40 may include the step 56 warning before or after step 50 or 54 of issuance. In this case, the method 40 may provide a warning, precautions and/or instructions (hereinafter "information") to the buyer through the device 14-1 data entry and communication, in respect of the application of a particular medical product. For example, the method 40 may control the device 14-1 data entry and communication at step 56, to provide written information, visual information, speech information, and combinations thereof.

In the present invention, it is assumed that the method 40 at step 56 can personalize the information for a particular customer using a biometric data and/or at least one response of the buyer.

4 shows an alternative exemplary variant of the method, the overall position 60, to transfer OTC, limited available medical products in the category of medical products for General sale.

The method 60 includes a step 62 where the vending machine 12 accepted a purchase request from the buyer on a specific over-the-counter, limited the available medical product 20. After acceptance, the method 60 includes a step 64 at which the method determines whether the request is for the purchase of the original buyer's request for the purchase or subsequent request for the purchase of a particular medical product. Then the method 60 calls the algorithm of choice if a purchase request is the initial request for the purchase, at step 66 or algorithm deselect, if a purchase request is a subsequent request for the purchase, at step 68.

After calling the appropriate algorithm method 60 requires the buyer to enter a response to each of the many issues and analyzes the information created by the selection algorithm or the algorithm deselect at step 70. Then, at step 72, the method 60 controls the vending machine via an algorithm select or deselect to grant or not to grant a particular medical product based on the answers.

In other embodiments, implementation of the method 60 may include the step 74 warnings or cautions before or after steps 70 and 72 of issuance. In this case, the method 60 may provide a warning, precautions and/or instructions (hereinafter "information") to the buyer through the device 14-1 data entry and communication in respect of the application of a particular medical product. For example, the method 60 may control the device on the om 14-1 data entry and communication at step 74, to provide written information, visual information, speech information, and combinations thereof.

The present invention also assumes that the method 60 at step 74 can personalize the information for a particular customer using a biometric data and/or at least one response of the buyer.

In the present invention it is also assumed that the stage 74 warning may contain a possible follow-up of the buyer licensed practical doctor or other practical doctor in relation to purchasing medical product, if it is specified on the label.

For example, the system 10 can provide data to contact the buyer with the manufacturer of the medical product or the owner of the system 10. When this contact with the buyer can be arranged in the form of follow-up, namely within a predefined period of time after purchase, to ensure that any critical information related to the safe and effective use of the product, and to determine whether the buyer has any questions, or whether to provide any follow-up in terms of the medical product. In a preferred embodiment, the system 10 can provide the data necessary for the subsequent observation that is in his way, which meets the requirements of the law "On transferability and accountability of health insurance" (HIPAA).

In another example, the system 10 may send a reminder to follow-up directly to the buyer. In some embodiments, the implementation of the system 10 can transmit directly to the buyer by e-mail, e-mail, telephone, text message, mail, reminding the buyer, for example, about the need to check his blood pressure below a predefined limit, or be checked by a doctor if the signs and symptoms of the disease that is being treated, become worse.

Next, figure 5 presents under the common position 80, an exemplary variant of the method of issuing medical products.

The method 80 includes a step 82 where the vending machine 12 accepted a purchase request from a buyer for a particular medical product 20. Then, after acceptance, the method 80 at step 84 causes the algorithm issuance of specific medicinal product.

After calling the appropriate algorithm method 80 at step 86 requires the buyer to enter a response to each of the many questions and view information issued by the algorithm at step 86. Then the method 80 at step 88 requires the buyer to enter biometric data. Then the way a step 90 determines to grant or not to grant a particular medical product based on the answers and, at least partially, on the basis of biometric data.

In the present invention it is also suggested that the way to 80 on the stage 90 may use biometric data and/or answers a buyer for the individualization of purchasing a medical product for the buyer. For example, the method 80 at step 90 may use biometric data (such as weight) and/or at least one response of the buyer (e.g., age)to identify at least one characteristic of the purchase. Characteristics of purchases that can be individualized way 80 based on the answers and, at least partially, on the basis of biometric data at step 90 may contain the dosage of the medical product, the use of the user instructions, warnings and other.

Thus, the method 80 may, at step 90 to determine not only the issue of whether or not a particular medical product based on the answers and, at least partially, on the basis of biometric data, but also to identify at least one characteristic of the purchase.

In some embodiments, the biometric data from step 88 can be entered locally on the vending machine 12 at step 92. For example, locally entered the data at step 92 can be entered into the system 10 through the device 14-1 connection or by connecting the device biometric measurements, submitted by buyer (not shown), the vending machine 12 through the device 14-1 data entry and communication, as explained above for Figure 1. In addition, the locally entered data at step 92, you can enter the measurement in step 94 biometric data directly on the vending machine 12 through the device 14-3 collection of biometric data, as explained above for Figure 1.

In other embodiments, the implementation of the purchaser may authorize in step 96 obtaining a vending machine 12 biometric data from the external diagnostic center 28 as described above for Figure 1.

Systems and methods in accordance with the present invention, by eliminating the need for interaction with a pharmacist or trained medical professional mediator, allow extradition OTC, limited available medical products in previously impossible.

In addition, in the framework of the present invention found that systems and methods in accordance with the present invention, in a preferred embodiment, allow in some cases the translation of medical products, having the status of a prescription, the status of a freely available, non-prescription and/or medical products, which have the status of limited available, the status is freely available.

Medical products, which the FDA already ut is Ardila for use by prescription, you can "translate" in the category of over-the-counter use, when installed in accordance with the requirements of the FDA, which, among other factors, the medical product is safe for use under the conditions specified on the label. Applied problems in the above "translation" usually require data about the actual use and comprehensive study labels to demonstrate that the product can safely and effectively be used without the supervision of a practitioner licensed by law to use or use of the product. In a preferred embodiment, the system 10 provides an interactive device additional measures and reconciliation, which, for example, provides the coordination with the requirements of the labels and, consequently, increases the degree of confidence associated with the translation of medical product from prescription status to OTC status.

In a preferred embodiment, systems and methods in accordance with the present invention provide a scheme of risk management and additional methods, which conveniently and effectively solves the problem of estimating the information content of labels, compliance labels, and prolonged use.

An exemplary variant of the method of transfer of prescription medical product in the OTC freely available medical prod the CT in accordance with the present invention is depicted in Fig.6 and indicated in General position 100.

The method 100 includes a step 102 of choice of drug at which a particular medical product, having the status of a prescription, is selected for transfer to the OTC status, freely available.

After the selection step, the method 100 includes the first stage 104 development, which creates a set of criteria for the initial issuance. A set of criteria for the initial issuance of specific medicinal product contains criteria sufficient for the responsible regulatory authority or control, such as the FDA, to change the status of the medical product to OTC status. Then the method 100 includes the second stage 106 development, which creates a set of questions to select, based on a set of criteria for the initial issuance.

At step 108 systematization method 100 orderly introduces a set of questions for selection in the selection algorithm. Then the method 100 includes the first stage 110 on which the medical product is loaded into a vending machine, and the second stage 112, in which the vending machine is installed in place of total sales. The method 100 includes a step 114 save the selection algorithm in the controller. Finally, the method 100 at step 116 issuing manages the vending machine via the controller, to produce the first commercial unit of the particular medical product only if the buyer is ü successfully performs the selection algorithm via the interface device 14.

In some embodiments, the implementation of the buyer may request a second or subsequent product medical product. In this case, the method 100 may include funds to support or enable a second or subsequent purchases of medical product with the status of OTC the same buyer.

In the above embodiment, shown in Fig.7, the method 100 further comprises the third stage 118 development, which creates a set of criteria prior to issue. A set of criteria for subsequent issuance for a specific medical product contains criteria sufficient for the responsible regulatory authority or control, such as the FDA, to prevent or to maintain the status of the medical product as the status of OTC product. Then the method 100 includes the fourth stage 120 of development, which creates a set of questions to deselect based on a set of criteria prior to issue.

In the second stage 122 systematization method 100 orderly introduces a set of questions to deselect the algorithm deselect. The method 100 at step 124 stores the algorithm deselect in the controller. Finally, the method 100 at step 126 the subsequent issuance manages a vending machine by the controller to issue a second or subsequent commodity units the units of a particular medical product, only if the buyer successfully performs the algorithm deselect through the device 14 of the interface.

Thus, the method 100 can successfully support the transfer of prescription medical products to OTC status in a manner that provides criteria for receipt of first and subsequent doses of a medical product in accordance with the approved label, avoiding the issue of medical product if not satisfied some selection criteria or cancel the selection.

It should be understood that the method 100 described above only apply when changing the status of a prescription medical product 20d to OTC status, freely available medical product 20a. Of course, in the present invention, it is assumed that the method 100 can be found, similarly, application for change of status of OTC, limited available medical product 20c to OTC status, freely available medical product 20a.

Next, Fig presents a sample implementation of the method 150 application system 10 containing the algorithms 24, 26 select and deselect.

Following the application of the system 10, as shown in Figa, the method 150 at step 152 may determine whether or not the buyer initial buyer. If the buyer is the initial purchaser, the method 150 at step 154 may, in some embodiments, implementation, to claim from the buyer the introduction of personal identification information, for example, but without limitation, name, address, date of birth, email address, phone number, gender, information about the propensity to allergies, about the drugs currently used, and other information. In the above embodiment, if the buyer is a repeat buyer, then the method 150 at step 156 requires the buyer to enter enough information to allow the system to cause the record of the customer stored in the system 10. After calling the method 150 requires the buyer to check and update the previously entered personal identification information.

In other embodiments, implementation of the system 10 may not require identification of the customer by entering personal information. The method 150 proceeds directly to step 158, described below.

Then the buyer selects the desired medical product 20 to be buying at step 158, and the buyer is required to check out the selection at step 160. After checking the desired product 20 method 150 causes the 24 automatic algorithm selection and algorithm 26 deselect for the desired medical product 20.

In the example shown, in which the desired medical product 20 I have is hypocholesterolemic drug, for example, by means of drugs "Statesboro" class, which are commercially produced by the owner of this application, the method 150 determines at step 162 whether the request is for the purchase from a particular customer on a particular product 20 by the first query 164 for the purchase or the second request 166 for purchase. It should be understood that in other examples of algorithms 24, 26 for other medical products, the method 150 may only need to establish differences first purchases from the latter purchases, while some algorithms 24, 26 for other medical products may require method 150 of establishing differences of each purchase from the others.

When the method 150 determines that a purchase request is the first request 164 to purchase, the system 150 uses the 24 automatic algorithm selection for a particular medical product 20. In the shown example, the system 150 uses the algorithm 24 automatic choice for the medical product.

On the contrary, when the method 150 determines that a purchase request is the second request 166 for purchase, the system 150 uses the algorithm 26 deselect selected for a particular medical product 20, namely the medical product.

Algorithms 24, 26 to automatically select and deselect determined at step 170, based on the information entered/verified at steps 154 and 156, whether a customer is male or female. Based on the results of the determination at step 170, the method 150 continues to use the proper area of algorithms 24, 26 to automatically select and deselect respectively.

When the method 150 determines at step 170 (Figa)that the customer is the original purchaser of a particular medical product 20 is a woman, then the method 150 continues to use the algorithm 24 is automatically selected as shown in Fig.8b. As shown in Fig.8b, the method 150 at step 172, based on the information entered/verified at steps 154, 156, determines a customer younger than 55 years, and gives to confirm the age of the customer at step 172. If the age of the ladies less than 55 years, and it is within childbearing age, the method 150 determines at step 174 whether the buyer pregnant, and, if so, determines at step 176 whether the customer is unable to pregnancy.

When the method 150 determines at steps 172 (age) and stages 174/176 that the customer is not pregnant, the method requires the ladies enter her cholesterol at step 178. Cholesterol can be entered at step 178 manually using device 14-1 data input through the connection provided by the user devices is the measurement of cholesterol to the system 10, by measuring the level directly in the system 10 or any other of the above-described method.

After receiving cholesterol shoppers way 150 through 24 automatic algorithm selection compares the phase 180 mentioned the level with the predetermined level for therapy. For example, if the level of cholesterol the ladies above a predefined level for therapy, i.e. as shown above 170 milligrams per deciliter (mg/DL), then the method 150 continues to use the algorithm 24 is automatically selected as shown in Fig.8d.

However, if the method 150 determines at any stage 174, 176 or 180 that the medical product 20 is not suitable to the buyer, the method notifies the buyer about the condition at step 182 and rejects the request for the purchase at step 184.

When the method 150 determines at step 170 (Figa)that the customer is the original purchaser of a particular medical product 20 and is male, the method 150 continues to use the algorithm 24 is automatically selected as shown in Figs. As shown below in Figs, the method 150, based on the information entered/verified at steps 154, 156, determines at step 186 whether the buyer is aged 45 years or older, and requests the buyer to confirm his age.

When the method 150 determines at step 186 that the man is a buyer who is in the appropriate age (i.e. the at the age of 45 years or older), the method requires the buyer to enter his cholesterol level at step 188. And again, the cholesterol can be entered at step 178 any of the above-described method. After receiving cholesterol buyer method 150 through 24 automatic algorithm selection compares at step 190 the received level at a predetermined level for therapy. For example, if the cholesterol level of the buyer above a predefined level for therapy, i.e. as shown above 170 mg/DL, the method 150 continues to use the algorithm 24 is automatically selected as shown in Fig.8d.

However, if the method 150 determines at any stage 186 or 190 that the medical product 20 is not suitable for a customer, the method notifies the buyer about the condition at step 192 and rejects the request for the purchase at step 194.

When the method 150 first determines that a specific buyer corresponds to the selected medical product 20 at step 180 (Fig.8b) or step 190 (Figs), the method will continue to use the algorithm 24 to automatically select to perform a suitability analysis therapy drugs Statesboro class for a buyer, as shown in Fig.8d, using many factors 196 risk.

As shown below in Fig.8d, the method 150 determines at step 198, does the buyer as is any other hypocholesterolemic drugs. The method 150 further identifies, suffer if the buyer liver disease, at step 200, or had previously negative reaction to any satinowye drugs, at step 202.

If the method 150 determines at steps 198, 200, 202 that the buyer continues to come for treatment satinowye drugs, the method queries at step 204, information relating to the specific risk factors for a buyer, and then determines at step 206, whether surpasses the number of risk factors, identified at step 204, a preset degree of risk. If the buyer continues to come for treatment satinowye drugs after step 206, the method 150 determines in step 208 whether the buyer is a drug that interacts with latinoam drug. If, after execution of step 208, the buyer continues to come for treatment satinowye drugs, then the method 150 proceeds to step 216 of issuance shown on Five.

As shown in Figi, the method 150, during step 216 issue, requires the buyer to confirm many of the warnings and instructions regarding medical product 20. The method 150 checks on the stage 216-1 that every traveler is confirmed(a), and then issues a corresponding number of medical what about the product 20 on the stage 216-2.

If the method 150 determines at steps 198, 200, 202 that the buyer is not pre suitable for the treatment of satinowye drugs, the method determines at step 210, discussed whether the buyer of the situation with his doctor did, however, approval. If at step 210 it is determined that the subject, the method 150 proceeds to step 206. However, if at step 210 it is determined that approval is not submitted, then the method 150 informs the buyer at step 212 that the medical product 20 is not suitable for the buyer, and, at step 214, rejects the request for the purchase.

As shown in Figa, when the method 150 determines at step 170, the second time buyer is a buyer specific medical product 20 is a woman, the method 150 continues to use the algorithm 26 deselect, as shown in Fig.8f. As shown in Fig.8f, the method 150, on the basis of the information verified at step 156 determines whether the customer still younger than 55 years, and requires the customer to confirm the mentioned age on stage 272. If the age of the ladies less than 55 years, and it is within childbearing age, the method 150 determines at step 274 whether the buyer pregnant, and if not, then determines at step 276, if the customer is unable to pregnant the minute.

When the method 150 determines at step 272 (by age) and stages 274/276 that the customer is not pregnant, the method requires the ladies enter its new cholesterol at step 278, established from the beginning of therapy satinowye drugs. Cholesterol can be entered at step 278 any of the above-described method.

After receiving cholesterol shoppers way 150 by means of algorithm 26 deselect compares mentioned the level with the maximum predetermined level for therapy on the stage 280-1 and with a minimum pre-specified level for therapy on the stage 280-2. For example, if the cholesterol level the customer is within the level for therapy from 130 mg/DL 170 mg/DL, the method 150 continues to use the algorithm 26 deselect, as shown in Fig.8d described above.

However, if the method 150 determines at any stage 274, 276, 280-1, or 280-2 that the medical product 20 is not suitable to the buyer, the method notifies the buyer about the condition at step 282 and rejects the request for the purchase at step 284.

When the method 150 determines at step 170 (Figa)that the second time buyer is a buyer specific medical product 20 and is male, the method 150 continues to use the algorithm 26 deselect, as shown in Figg. As shown the alley on Figg, the method 150, on the basis of the information verified at step 156 determines in step 286, if the buyer-male age 45 years or older, and requests the buyer to confirm his age.

When the method 150 determines at step 286 that the man-the buyer is in the appropriate age, the method requires the buyer to enter his new cholesterol at step 288, established from the beginning of therapy satinowye drugs. Cholesterol can be entered at step 288 any of the above-described method.

After receiving cholesterol buyer method 150 by means of algorithm 26 deselect compares mentioned the level with the maximum predetermined level for therapy on the stage 290-1 and with a minimum pre-specified level for therapy on the stage 290-2. For example, if the cholesterol level of the buyer is within the level for therapy from 130 mg/DL 170 mg/DL, the method 150 continues to use the algorithm 26 deselect, as shown in Fig.8d.

However, if the method 150 determines at any stage 286, 290-1 or 290-2 that the medical product 20 is not suitable to the buyer, the method notifies the buyer about the condition at step 292 and rejects the request for the purchase at step 294.

When the method 150 first determines that a specific buyer is suitable for using the data of the medical product 20, on stage, 280-2 (Fig.8f) or stage 290-2 (Figd), the method continues to use the algorithm 26 deselect to perform a suitability analysis therapy satinowye drugs for the buyer, as shown in Fig.8d, using many factors 196 risk.

In some embodiments, the implementation of the algorithm 26 deselect determines, whether the purchaser in the prescribed dosage. For example, in the successful purchase when the algorithm is executed 24 automatic selection system 10 may provide a number of medical product 20, which must be taken within a predefined period of time. Date subsequent attempts to purchase the same medical product 20 algorithm 26 deselect may determine not been rejected by the buyer from the desired route of administration of the medicinal product. Thus, the system 10 may determine not come if the buyer back for the subsequent purchase of medical product too quickly, which may indicate the reception of a medical product in too large doses. In an alternative embodiment, the system 10 may determine not come if the buyer back for the subsequent purchase of medical product too late, which may indicate insufficient in number receiving medical product.

Accordingly and in this way the system is and 10 may provide interactive approvals for additional measures necessary to meet the requirements established by the FDA for translation mentioned prescription drugs and/or translation of medical products with the status of limited recourse to the products to total sales.

In addition, the system 10 can be configured to support a buyer in the selection of a suitable medical product 20, respectively, symptoms or disease States, which currently suffers from the buyer. For example and as shown previously in figure 1, the controller 16 may include an algorithm 32 rebounds, permanently stored in the controller.

The algorithm 32 selection is composed with the ability to provide exemplary symptoms or disease cases to the buyer through the device 14-1 in the visual or acoustic form. In the context of this application, the term "visual form" must mean that approximate the symptom or the disease state is provided to the buyer in non-textual form, for example, but without limitation, in the form of a picture. Thus, the algorithm 32 selection allows the buyer to match your specific symptom or condition of the disease presents with estimated symptom or condition of the disease. After the buyer identifies your symptom or condition of a disease by means of algorithm 32 selection, the controller 16 provides the equately, through the device 14-1, a list of at least one medical product 20 being in the vending machine 12, which is suitable to the above mentioned symptom, or disease state.

For example, customer calls, which suffers from cough and intends to buy OTC freely available remedy for cough. System 10 determines whether the buyer help, via an algorithm 32 rebounds, in the process of choosing the right medical product against cough buyer. After selecting the algorithm 32 selection may submit to the buyer a lot of different voiced examples cough through the device 14-1 data entry and communication.

In the above example, the system 10 may prompt the buyer, like if his cough sound wet or productive cough, and then play the recording sample wet cough with loudspeaker 14-1 on the vending machine 12. If the sample is wet cough is not selected, the system 10 may prompt the buyer, like if his cough sound dry or non-productive cough, and then play a recording of a sample of dry cough with loudspeaker 14-1.

The algorithm 32 selection can continue to provide exemplary symptoms or disease state to the buyer until the buyer does not identify the symptom or condition of the disease, which(OE) ratio is esthet his particular condition. After selecting a specific symptom or condition of the disease by means of algorithm 32 selection, the system 10 can offer the customer additional products 20 stored within the vending machine 12, which are suitable to the above symptoms or disease States.

In some embodiments, the implementation of the algorithm 32 selection may represent only such medical products 20, which is not peculiar to negative interactions with healthcare products, currently used by the buyer, or medical conditions (e.g. high blood pressure)acting on the buyer.

However, the algorithm 32 selection may also recommend the user to consult a medical specialist or doctor if not picked up not one consistent symptom of a condition or disease, if none medical product 20 is not suitable for a purchaser for other reasons (for example, due to age, gender, possible drug interactions and such dangers as, for example, allergies, etc. and any combinations thereof.

It should be understood that the algorithm 32 selection described above, for example using a selection of the symptom or condition of the disease by sound. Of course, in the present invention, it is assumed that the algorithm 32 selection may provide visual coordination of si is of Tomov or disease States, for example, by providing non-textual visual examples of States, for example, but without limitation, rashes on the skin that needs treatment.

It should also be understood that the algorithm 32 selection described above as applied to medical products 20a without restriction treatment. However, in the present invention, it is assumed that the algorithm 32 selection may relate to the use of any medical product 20, namely products without any restrictions treatment (i.e. products 20a) and products with restricted circulation (i.e. products, 20b, 20c, 20d).

In some embodiments, the implementation of the present invention, it is assumed that the system 10 can be implemented with the possibility of marketing a particular medical product. In this case, the system 10 may include an algorithm 32 selection only for these specific medical product. In the process of applying the buyer will use the system 10 for the particular medical product that the buyer is interested to buy through a system designed for these specific medical product. Then, the controller 16 contained within the system 10 may allow the buyer to call the algorithm 32 selection and submit to the buyer a multitude of exemplary symptoms or disease States specific to MEDICINSKOGO product through the device 14 data entry and communication. Thus, the buyer can choose at least one symptom or one state of the disease from a variety of exemplary symptoms or disease States, when at least one symptom or one state of the disease are consistent with those currently experienced by the buyer. After the symptom of a condition or disease(nd) is the buyer selected(on) of algorithm 32 selection, the system 10 may be operated in such a manner as described above. In particular, the system 10 can start the application of algorithms 24, 26 select and/or deselect respectively.

In the drawings, and particularly figure 9, shows an alternative exemplary variant of the implementation of the system 310 issuance of medical products. For clarity, a detailed description of the constituent parts of the system 310, which perform a function similar and/or analogous functions described above for system 10, is not given.

In a preferred embodiment, the system 310 is designed for use in the issuance of medical products, 20b, 20c and 20d, which are subject to the requirements of the restriction of the circulation, without the necessity of an interaction of the customer with the licensed practical doctor. In addition, the system 310 is designed for use in the issuance of medical products 20a which are not subject to the limitation of the treatment, the mouth of Blencoe, at least one regulator, and the restriction of circulation imposed by the retail organization and/or manufacturer of the product. In one embodiment, the system 310 provides the customer a printed receipt or record 340 operations of sale, which can be represented trade worker, pharmacist or pharmacy staff, located in the terminal. In this case, the staff can take a medical product from a protected space on the basis of printed receipts or records of transactions of sale and purchase (hereinafter "account") and to execute a sale. Record 340 operations of purchase and sale may be indicative of a medical product or, in some embodiments, implementation, can be a proof of purchase mentioned medical product through the system 310. In other embodiments, the implementation record 340 operations of purchase and sale may be equivalent to a medical questionnaire, for example questionnaires, which is commonly used in the UK and asks the pharmacist to purchase the limited available medical products 20c.

Thus, entry 340 may be a card that allows its holder to buy medical product that is listed in the record. In an alternative embodiment, the system 310 may, after successful completion of a selection or cancellation of choice is, to request from the user for the electronic payment for the product to record 310 was also a cheque for the purchase of the product.

Thus, the system 310 provides the customer a printed receipt or record 340 operations of sale, which can be represented trade worker, pharmacist or pharmacy staff, located in the terminal together with the medical product. In this case, the buyer can take a medical product from the normal place of storage and present the product and record sales employee in the terminal to perform the operation of sale.

In the variants of implementation, in which the entry 340 is a card that allows its holder to buy medical product that is listed on the records, it is assumed that the sales associate may not perform the operation of sale of medical product without the corresponding entry 340. For example, an employee may receive an instruction not to perform the operations of sale of some products without a corresponding entry 340. In other examples, system trading terminal (not shown), such as a cash register may be configured to prevent the operations of purchase and sale with no corresponding entry 340.

System 310 provides effective leadership to the buyer by the follower of the spine issues concerning the history of the disease and/or medical product, and also provides about the specific product information that is of interest and important for informing the buyer.

Thus, the system 310, like the above-described system 10, provides an electronic device for a significant reduction in communication time with a well-informed intermediary (i.e. a licensed practical doctor), or its replacement, due to collection of critical parts, which provides a well-informed broker, and also provides more effective methods for safe and effective use of prescription or limited available medical products freely available in the Department. In addition, the system 310 can also be used to facilitate the purchase of medical product from the limited available Department, for example, as is customary in the UK, and/or to facilitate the purchase of medical products on lists 3 and 4, for example on such lists that exist in Australia.

In particular, the system 310 provides an interactive computer having access to at least one of 24 automatic algorithm selection for a particular product, the algorithm 26 deselect specific product algorithm 32 selection and any combination thereof.

However, instead of giving me izinski products 20a, 20b, 20c and 20d directly from the system 310, as in the case of system 10, the system 310 is configured to issue write 340 medical product selected by the buyer. The system 310 issues a record 340 only if the buyer meets the conditions for medical products 20a, 20b, 20c and 20d, which is determined by the algorithm 24 automatic selection for a particular product or limitations set by the label, manufacturer, retail trade enterprise or other government agencies.

For subsequent requests on a specific medical device 20a, 20b, 20c and 20d, the system 310 may issue a subsequent entry 340 on the particular medical product if the buyer retains its compliance with the conditions for a medical product that is determined by the algorithm 26 deselect in accordance with the previous and new information entered by the buyer, or limitations specified by the label, manufacturer, retail trade enterprise or other government agencies.

Record 340 contains data 342, printed or otherwise inscribed into it. Data 342 may contain information such as, for example, but without limitation, the identification information of the customer, a check commercial enterprise, product description, product image, the image of the customer and other data, Rel is which are relevant to the customer, medical product or transaction of sale.

As shown in Fig.9, the system 310 includes a device 312 formation records containing at least one device 314 human-machine interface. The system 310 also includes a controller 16 that is associated with the device 312 of the formation and at least one interface device 14-1, 14-2, 14-3 and 14-4.

The device 312 forming the record may also include a printer or encoder 314 and/or may be electrically connected with the printer or encoder 314 to maintain a record 340.

In the present embodiment, system 310 is shown that the controller 16 is removed from the device 312 forming recording and exchanging data over the network 22. However, in the present invention, it is assumed that the controller 16 can reside in the structure of the device 312 forming the recording. In addition, it is assumed that the system 10 may include two controllers, one resides in the structure of the device 312 forming recording and one remote device 312 forming the recording, with two controllers communicate over the network 22. The network 22 may be any desired communication network, for example, but without limitation, a distributed network, the Internet and other networks.

For example and as shown in Figure 10, in the present invention, it is assumed that th is device 312 forming the recording may be a personal computer 350, associated with the controller 16 via the Internet 22. In this case, the personal computer 350 may be located in the terminal or can be in the buyer's home, workplace, etc. Thus, the system 310 allows the buyer to apply to the controller 16 from any desired location on the Internet and, after a successful interaction with the at least one algorithm 24, 26, 32, allows the buyer to print the record 340 printer (not shown), which says that the buyer has the right, and that the medical product is available for use. Then the buyer has a record 340 in the store to buy medical product record view 340 staff shop. View record 340 to store staff can be performed simultaneously with the submission of the required product, which the buyer of a retail store. Alternatively, entry 340 can be presented to staff, then the staff can remove the desired product from the protected space.

The system 310 is used with any of the above methods 40, 60, 80, 100, and 150. However, instead of issuing a medical product, the system 310 generates a record 340. After the entry 340 is formed, the buyer can submit an entry to the trade employee who is located in the terminal.

Instead of providing the buyer account transactions of sale and purchase, as explained in the above embodiments, implementation, system 410 issuing medical products sends by mail the purchased product directly to the customer. Thus, the system 410 allows the buyer to contact the controller 16 of any desired place and, after a successful interaction with the at least one algorithm 24, 26, 32, allows the buyer to obtain the desired medical product only if the buyer has the right, and medical product suitable for use.

The system 410 is used with any of the above methods 40, 60, 80, 100, and 150. However, instead of issuing a medical product, the system 410 provides a result of the delivery of the requested medical product is not orestano to the buyer by mail.

In some embodiments, the implementation of the system 10, 310 and/or 410 may be configured to ensure compliance with Federal requirements and/or requirements of States controlled circulation of medical products 20b, for example, but without limitation, PSE-containing and other products. For example, system 10, 310 and/or 410 may be performed with the print operations of sale and/or official reports about them in a responsible organization. Systems 10, 310 and/or 410 may be configured to send the recording of the sale to another location, for example in the above-mentioned organization, which will validate the user selected product and quantity in shopping terminal. Systems 10, 310 and/or 410 may be configured to collect and official reports information about the records of purchases of specific buyers of medicinal products which are subject to the liabilities associated with the potential misuse. Documentation may include the number sold of product, date of sale and the total number of products sold.

In accordance with the above, one alternative implementation of the present invention relates to a method for issuing medical products, in this case, the method comprises: a step of identifying a particular medical product having a hundred the condition of limited circulation; the installation phase of the vending machine in a place of total sales, and vending machine contains the device man-machine interface associated with the controller; a step of preserving the stock of a particular medical product in a vending machine; a step of preserving electronic procedure to automatically select a controller; and a stage control a vending machine by the controller for the grant of the first commercial unit of the particular medical product only if the buyer successfully performs the automatic choice for the initial request to purchase a particular medical product through the device interface.

In one embodiment, the above method specific medical product contains OTC, limited available medical product or freely available, non-prescription medical product. In some embodiments, the implementation of the method may further comprise the step of preserving electronic procedures deselect the controller and, if required, may include stage managing a vending machine by the controller to issue a second or subsequent trademark of units of a particular medical product only if the purchaser successfully completes the procedure for cancellation of choice for the second or subsequent request by the code of criminal procedure specific medical product via the interface of the buyer. In other variants of implementation, the method further comprises the step of collecting the biometric data from the buyer as part of the procedure deselect and, if required, may include the step of analyzing the biometric data from the buyer as part of the procedure deselect. In yet some additional embodiments, the implementation of the method further comprises the step of providing information to the buyer and, if required, may include the stage of individualization information on the basis of the procedure of automatic selection procedure deselect and any combination thereof, and/or includes a step of personalizing information based on the biometric data. In yet another embodiment, the method further comprises the step of managing a vending machine by the controller, for presenting instructions to the buyer if the controller determines that the buyer has not successfully completed the cancellation process of selection, with instructions include steps required to successfully perform the procedure deselect. In yet another embodiment, the procedure deselect may contain automatic limitation of the duration of a particular medical product to a pre-specified duration.

In another embodiment, the above-mentioned method, the method will add the flax contains the stage of gathering information from the buyer as part of the procedure of automatic choice. The method may further comprise the step of collecting the biometric data characterizing the buyer from the buyer as part of the procedure of automatic choice. In some embodiments, the implementation phase of collecting the biometric data includes a step of measuring biometric data on the vending machine. In other embodiments, implementation of the method may further comprise the step of analyzing the biometric data from the buyer as part of the procedure of automatic choice. In other embodiments, the implementation phase of collecting the biometric data includes a step of request to the buyer to manually enter biometric data in a vending machine or scan biometric data in a vending machine carrier of information submitted by the buyer. In yet some additional embodiments, the implementation phase of collecting the biometric data may include: the stage of the request to the buyer to install and electrically connect the biometrical measurements submitted by the buyer, with a vending machine; and a stage control a vending machine for call of biometric data from the biometric measurements provided by the buyer. In yet another embodiment, the step of collecting the biometric data may include: the step of saving the biometric data in the database associated with the external di is Gnostic or laboratory center; the stage of issuance of the permit, during the procedure of automatic selection, vending machine to cause biometric data from a database over a network connection.

In an additional embodiment of the method described above, the method may further comprise the step of providing the purchaser of these warnings and safety measures during the procedure of automatic selection.

In an alternative embodiment of the method described above, the method may further comprise the step of managing a vending machine by the controller to provide instructions to the buyer if the controller determines that the buyer does not perform successfully the process of automatic selection, with instructions include steps required for successful execution of the procedure of automatic choice. In some embodiments, the implementation of the instructions can include instructions to seek medical advice.

In another alternative embodiment of the method described above a specific medical product contains prescription product.

In accordance with the foregoing second variant implementation of the present invention relates to a method of issuing a medical product from the vending machine in a place of total sales, the method includes: an acceptance step for the dew on the purchase at the vending machine from the buyer on a specific medical product with limited appeal; the step of determining whether the request is for the purchase of the initial request for the purchase or subsequent request for the purchase from the buyer on a particular medical product; stage call automatic algorithm selection for the particular medical product if a purchase request is the initial request for purchase; stage call algorithm deselect a specific medicinal product, if a purchase request is a subsequent request for the purchase; the stage of submission of the buyer requirements to enter a response to each of the many questions generated by the algorithm to automatically select or algorithm deselect; and phase control of a vending machine by automatic algorithm selection or cancellation algorithm of choice to to grant or not to grant a particular medical product based on the answers.

In one embodiment, the above-mentioned method, the method further comprises the step of calling the stored data from the responses of the buyer, if a purchase request is a subsequent request for the purchase.

In another embodiment, the above-mentioned method, the method further comprises the step of establishing contact with the buyer, on the basis of information for the buyer, after the automatic algorithm selection or algorithm deselect issues specific the first medical product.

In another embodiment, the above method the step of presenting to the buyer requirements to enter a response further comprises the step of collecting the biometric data from the buyer. The step of collecting the biometric data may include the step of measuring biometric data on a vending machine, the enquiry stage to the buyer to manually enter biometric data in a vending machine or the stage of the request to the buyer to scan or read the biometric data in the vending machine. In other embodiments, the implementation phase of collecting the biometric data may include: the stage of the request to the buyer to install and electrically connect the biometrical measurements submitted by the buyer, with a vending machine; and a stage control a vending machine for call of biometric data from the biometric measurements provided by the buyer. In addition, the step of collecting the biometric data may include: the step of saving the biometric data in the database associated with the external diagnostic or laboratory centre; and the stage of submission of the buyer requirements to authorize, as part of the answer, vending machine to cause biometric data from a database over a network connection.

In accordance with the foregoing, another variant of implementation of the present invention refers to is the procedure of issuance of a medical product from the vending machine in a place of total sales, the method includes: an acceptance step in a vending machine of a purchase request from a buyer for a particular medical product; stage call algorithm issuance for the particular medical product; the stage of submission of the buyer requirements to enter a response to each of the many questions generated by the algorithm of issuance; the stage of collection of biometric data from the customer; and the step of determining whether to issue or not a particular medical product based on the answers and based at least in part, the biometric data.

In one embodiment, the above method specific medical product may be limited to selling a medical product or over-the-counter medical product.

In another embodiment, the above-mentioned method, the step of collecting the biometric data includes a step of measuring biometric data on a vending machine, or the stage of the request to the buyer to manually enter biometric data in a vending machine, or the stage of the request to the buyer to scan or read the biometric data in the vending machine.

In yet another embodiment, the above-mentioned method, the step of collecting the biometric data includes a step of request to the buyer to install and electrically connect the biometrical measurements submitted by the buyer,with a vending machine; and the stage management of a vending machine for call of biometric data from the biometric measurements provided by the buyer.

In yet another different embodiment of the above method the step of collecting the biometric data includes a step of saving the biometric data in the database associated with the external diagnostic or laboratory centre; and the stage of issuance of the permit, during the procedure of automatic selection, vending machine to cause biometric data from a database over a network connection.

In yet another additional embodiment, the above-mentioned method, the method includes a step of individualization at least one characteristic of a purchase request based at least partially biometric data. In this case, at least one response may contain a dose of the medical product, the instructions for use, warnings and any combination thereof.

In accordance with the foregoing, another variant implementation of the present invention relates to a method of transfer of prescription medical product in the OTC freely available medical product, the method includes: a step of selecting a specific medical product, having the status of a prescription; the stage of development of the criteria set original is the first issue for the particular medical product, moreover, the set of criteria for the initial issuance is sufficient for the responsible regulatory authority has approved the change of status of a particular medical product to OTC status; the stage of development of a set of questions for automatically selecting, focusing on product and customer-centric, based on a set of criteria for the initial issuance; stage ordered input set of questions for the automatic selection algorithm for automatic selection; the loading phase of a particular medical product in a vending machine containing the device man-machine interface, electrically connected with the controller; the installation phase of the vending machine in a place of total sales; the step of storing automatic algorithm selection controller; and stage control a vending machine via the controller, to produce the first commercial unit of the particular medical product only if the buyer successfully executes the automatic algorithm selection via the device interface.

In one embodiment, the above-mentioned method, the method further comprises the step of limiting the number of trade items for a buyer.

In another embodiment, the above-mentioned method, the method further comprises: the step of developing a set of criteria will follow what her issue for a particular medical product, moreover, the set of criteria further issue is sufficient for the responsible regulatory authority made or kept OTC status; the stage of development of a set of questions to deselect focused on product and customer-centric, based on a set of criteria prior to issue; stage ordered input set of questions to deselect the algorithm deselect; stage saving algorithm deselect the controller; and a stage control a vending machine by the controller to issue additional commercial unit of the particular medical product only if the buyer successfully performs the algorithm deselect via the interface device interface.

In accordance with the foregoing additional option of implementing the present invention relates to a system of issuing medical products, with the above system contains: vending machine, limiting the storage location and the storage location is configured to accommodate the at least one medical product limited treatment and at least one medical product unrestricted circulation; at least one device human-machine interface; a controller associated with a vending machine and at least one interest is so device; and an algorithm for automatic selection, permanently stored in the controller, for each of the medical products limited circulation in the place of storage, and a controller configured to determine, after selecting a specific medical product limited recourse by the buyer via at least one interface device, whether the choice of a particular medical product limited treatment of the first request or the second request for the particular medical product limited circulation, and the controller is configured to present to the buyer requirements to perform an algorithm for automatic selection, if the request is a first request, and a controller configured to issue a specific medical product limited circulation only in the case if the buyer successfully executes the automatic algorithm selection.

In one embodiment, the above-mentioned system controller is configured to present to the buyer requirements to enter personal information about the buyer via at least one interface device, and the controller is configured to determine, based on the selection of medical limited product handling and personal information about the buyer, whether the choice of a particular medical item is of oduct limited treatment of the first query or the second query.

In another embodiment, the above system further comprises an algorithm deselect permanently stored in the controller, for each medical product limited circulation in the place of storage, and the controller is configured to present to the buyer requirements to run the algorithm deselect, if the request is the second request, and a controller configured to issue a specific medical product limited circulation only if the buyer successfully executes the algorithm to remove the selection.

In an additional embodiment, the above-mentioned system controller is configured to, after selection by the buyer of a particular medical product unrestricted circulation through at least one interface device, sales of a particular medical product unrestricted circulation without any requirement to enter additional information about the buyer.

In yet another additional embodiment, the above-mentioned system, the automatic algorithm selection depends on the age of the buyer or depends only on the identity of the buyer, the buyer's age and the number of purchases by the buyer of a particular medical product limited circulation within the predefined periodaverage, when a particular medical product limited treatment contains pseudoephedrine or any restricted by age medical product. In some embodiments, the implementation of the controller can be electrically connected with many vending machines, and the controller stores information about each buyer on the many vending machines that the number of purchases of a particular medical product limited treatment was based on purchases by the buyer on the many vending machines.

In yet another embodiment, the above-mentioned system, at least one interface device includes at least one input device and communication. In some embodiments, the implementation of the input device and data communication may include a device selected from the group consisting of a screen of the video display, a standard alphanumeric keyboard, mouse, or pointing device, touch screen, reader, credit card reader and barcode, speaker, microphone, voice recognition, printer port, a wired communication port, wireless, and any combinations thereof. In other embodiments, the implement controller is configured to control at least one input device and communication when trading the car is at no use, to view advertising, advertising of drugs and/or information about drugs to people in the vicinity of the vending machine.

In another embodiment, the above system interface devices contain at least one identification device, and, in some embodiments, implementation, identification device selected from the group consisting of a device for reading magnetic strips, barcode, fingerprint scanning, scanning iris recognition, face recognition, scanning DNA and any combinations thereof. In the above-mentioned embodiment, it is assumed that the automatic algorithm selection may require biometric data, and the controller may be configured to issue a specific medical product limited circulation only if the biometric data meet the parameters of biometric data in the algorithm for automatic selection. In some embodiments, the biometric data is read from a user-supplied maps of the history of the disease or medical diagnostic card mentioned device.

In yet another embodiment, the above-mentioned system, at least one interface of the device is the STV contains, at least one device biometric data. In some embodiments, the implementation of an algorithm for automatic selection requires biometric data, and a controller configured to issue a specific medical product limited circulation only if the biometric data meet the parameters of biometric data in the algorithm for automatic selection. In other embodiments, the implementation of at least one device biometric data includes a device selected from the group consisting of a blood pressure monitor, monitor blood glucose, thermometer, infrared analyzer, acid-base balance of the blood and any combinations thereof.

In yet another embodiment, the above-mentioned system, at least one interface device includes at least one payment device. In some embodiments, the implementation of at least one payment device comprises a device selected from the group consisting of reader credit card reader, a debit card, the device receiving paper money, the device receiving coins and any combinations thereof. In other embodiments, the implement controller is configured to determine the cost of purchasing a medical product on the basis of the information on the insurance provider, entered by the buyer.

In additional embodiments, implementation of the above system, the controller may be configured to communicate with the database in the external diagnostic or laboratory center to receive biometric information about the customer after approval from the buyer via at least one interface device, or may be configured to control the storage location to store at least one medical product under ambient conditions of storage, air-conditioned storage conditions or any of their combinations.

In yet some additional embodiments, implementation of the above system, the storage location contains many places of storage, and vending machine and/or controller may be configured to manage multiple storage locations for storing at least one medical product under conditions suitable for each medical product, while in some embodiments, the implementation of many storage locations contains an auxiliary device attached to the block grant.

In yet another additional embodiment, the above system vending machine includes at least one sensor associated with the controller, the controller configured to control the internal Zap the sa medical products in storage location using, at least one sensor.

In accordance with the foregoing additional option of implementing the present invention relates to a method of marketing a medical product, with the above-mentioned method comprises: the step of providing a controller that contains the selection algorithm is constantly stored in the controller; a step of allowing the buyer to cause the selection algorithm; step control algorithm selection to provide to the buyer a multitude of exemplary symptoms or disease States through at least one input device and data connection in visual or audible form; a step of allowing the buyer to choose at least one symptom or condition of a disease from a variety of exemplary symptoms or disease States, when, at least one symptom or condition of a disease consistent with those currently experienced by the buyer; and the management phase selection algorithm to provide a list of at least one appropriate medical product against at least one of the selected symptom or condition of the disease.

In one embodiment, the above-mentioned method, the method further comprises: the step of providing the buyer the opportunity to choose a specific medical product from the list; and the stage in the management of the vending machine for issuing a particular medical product. In some embodiments, the implementation phase control a vending machine for issuing a specific medical product contains: stage call automatic algorithm selection for the particular medical product if a purchase request is the initial request for the purchase; and the stage management of a vending machine by the controller for the grant of the first commercial unit of the particular medical product only if the buyer successfully executes the automatic algorithm selection via at least one input device and communication. In other embodiments, the implementation phase control a vending machine for issuing a specific medical product contains: stage call algorithm deselect a specific medicinal product, if a purchase request is the second request for the purchase; and the stage management of a vending machine by the controller, to provide the particular medical product only if the buyer successfully executes the procedure deselect through at least one input device and communication. In the above embodiment, the phase control a vending machine for issuing a specific medical product may further comprise: a step of collecting the biometric data from the customer; and a detection phase, to give liili no specific medical product, based on the responses, and based at least in part, the biometric data.

In another embodiment, the above-mentioned method, the method further comprises: the step of providing the buyer the opportunity to choose a specific medical product from the list; and stage management controller to maintain a record of transactions of purchase and sale of a particular medical product. In the above method, the step of managing a vending machine for issuing a specific medical product may contain: stage call automatic algorithm selection for the particular medical product if a purchase request is the initial request for the purchase; and the stage management of a vending machine by the controller for the grant of the first commercial unit of the particular medical product only if the buyer successfully executes the automatic algorithm selection via at least one input device and communication. In addition, the phase control a vending machine for issuing a specific medical product may contain: stage call algorithm deselect a specific medicinal product, if a purchase request is the second request for the purchase; and the stage management of a vending machine by the controller to issue a particular medical product only is in the case if the buyer successfully performs the algorithm deselect through at least one input device and communication. In addition, the phase control a vending machine for issuing a specific medical product may further comprise: a step of collecting the biometric data from the customer; and the step of determining whether to issue or not a particular medical product based on the answers and based at least in part, the biometric data. In other embodiments, implementation of the method may further comprise the step of presenting to the buyer requirements to submit a record of transactions of purchase and sales officer, sales officer provides the buyer the particular medical product only when receiving the write operations of sale and/or require the buyer to get a specific product from a display rack for retail sale; and stage presentation to the buyer of the requirement to submit a record of transactions of sale and specific product sales employee.

In yet another embodiment, the above-mentioned method, the step control algorithm of matching symptoms to provide many exemplary symptoms include: stage management, at least one input device and connection for playback of the sound sample for the buyer, and in some VA is Ianto implementation of a sound sample contains sound, selected from the group consisting of wet cough, dry cough and any of their combinations.

In yet some additional embodiments, implementation of the above method, the step control algorithm of matching symptoms to provide a list of at least one appropriate medical product against at least one of the selected symptom contains: stage view only such medical products, which is not peculiar to negative interactions with health care products, currently used by the buyer, or medical conditions, applicable to the buyer. In an alternative embodiment, the phase control algorithm of matching symptoms to provide a list of at least one appropriate medical product against at least one of the selected symptom may include: stage view only such medical products, which are not characteristic of negative interactions with medical conditions, applicable to the buyer.

In accordance with the foregoing, another additional option of implementing the present invention relates to a method of marketing a particular medical product, with the above-mentioned method comprises: the step of providing a controller that contains the selection algorithm is constantly stored in the controller for a specific med the medical product; the step of providing the buyer an opportunity to cause selection algorithm; step control algorithm selection to provide to the buyer a multitude of exemplary symptoms or disease cases for a particular medical product through at least one input device and communication; a step of allowing the buyer to choose at least one symptom or condition of a disease from a variety of exemplary symptoms or disease States, when at least one symptom of a condition or disease consistent with those currently experienced by the buyer; and the detection phase is the request for the purchase of the initial request for the purchase or subsequent request for the purchase of from a buyer on a particular medical product; stage call automatic algorithm selection for the particular medical product if a purchase request is the initial request for purchase; stage call algorithm deselect a specific medicinal product, if a purchase request is a subsequent request for the purchase; the stage of submission of the buyer requirements to enter a response to each of the many questions generated by the algorithm for automatic selection or cancellation algorithm of choice; and the step of providing with an algorithm to automatically select or al is aritma deselect the buyer the opportunity to buy the particular medical product based on the answers.

In one embodiment, the above method the step of providing to the buyer the opportunity to buy a specific medical product includes a step of managing a vending machine by automatic algorithm selection or cancellation algorithm of choice for the issuance or denial of a particular medical product based on the answers.

In another embodiment, the above method the step of providing to the buyer the opportunity to buy a specific medical product includes a step of managing a vending machine by automatic algorithm selection or cancellation algorithm of choice for whether or not to grant write operations of purchase and sale that characterize a particular medical product based on the answers.

Of course, in the present invention it is assumed that these ways of implementation can be applied in any desired combination with one another.

It should also be noted that the terms "first", "second", "third", "upper", "lower", etc. can be used in the present description to modify various elements. Mentioned means modifications do not involve spatial, sequential, or hierarchical ordering of modifiable elements, unless specifically stated otherwise.

Above the present invention is described with references is on, at least one exemplary variant implementation, however, specialists in the art should understand that the details allow various changes and replacement of equivalents, is not beyond the scope of the present invention. In addition, you can create numerous modifications to bring specific situations or material in accordance with the principles of the invention without going beyond its scope. Therefore, it should be borne in mind that the present invention is not limited to a specific(and) option(s) offered(and) as a supposed best option, but that the invention will include all embodiments of within the scope of the claims appended claims.

1. A way to market a medical product, with the above-mentioned method contains the following steps:
storing electronic automatic selection relating to the medical product, in the controller;
retain electronic procedure deselect related to the medical product, in the controller;
give the potential buyer a medical product to cause the electronic procedure to automatically select and deselect;
control the controller via e-automatic procedure the selection, to ensure that write operations for a medical product only if the potential buyer successfully performs the automatic choice for the initial request for the purchase of medical product; and
control the controller via e cancellation of choice to ensure recording of transactions for medical product only if the potential purchaser successfully completes the procedure to cancel a selection, for the second or subsequent request for the purchase of medical products.

2. The method according to claim 1, wherein the medical product contains freely available over-the-counter medical product.

3. The method according to claim 1, in which the specific medicinal product contains OTC, limited available medical product.

4. The method according to claim 1, further containing the step of collecting the biometric data characterizing the buyer, potential buyer as part of the procedure of automatic selection.

5. The method according to claim 4, in which the step of collecting the biometric data includes a management controller for measuring biometric data of a potential buyer.

6. The method according to claim 4, further containing the step of analyzing the biometric data characterizing the buyer, as part of the procedure of automatic selection.

7. The method according to claim 4, in which step the boron biometric data, characterizing the buyer contains the enquiry stage to the potential buyer to manually enter biometric data to the controller.

8. The method according to claim 4, in which the step of collecting the biometric data characterizing the buyer includes a step of allowing the potential buyer to scan or read biometric data controller with the information medium provided by the buyer.

9. The method according to claim 4, in which the step of collecting the biometric data characterizing the buyer contains the following stages:
ask the potential buyer to install and electrically connect the biometrical measurements submitted by the buyer, with the controller; and
control the controller to call the biometric data characterizing the buyer, from biometric measurements provided by the buyer.

10. The method according to claim 4, in which the step of collecting the biometric data characterizing the buyer contains the following stages:
retain biometric data characterizing the buyer, in a database associated with the external diagnostic or laboratory centre; and
issue resolution during the procedure of automatic selection, the controller to cause biometric data from a database over a network connection.

11. The method according to claim 1, additionally containing the tap gather information from a potential buyer as part of the procedure of automatic selection.

12. The method according to claim 11, further containing the step of personalizing information based on the procedures for the automatic selection procedure deselect and any combinations thereof.

13. The method according to claim 11, further containing the step of personalizing information based on the biometric data characterizing the buyer.

14. The method according to claim 1, additionally containing a phase controller for submission instructions prospective buyer if the controller determines that the potential buyer has not fulfilled successfully the process of automatic selection, with instructions include steps required for successful execution of the procedure of automatic selection.

15. The method according to claim 1, additionally containing a phase controller for submission instructions prospective buyer if the controller determines that the potential buyer has not successfully completed the cancellation process of selection, with instructions include steps required for successful execution of the procedure, remove the selection.

16. The method according to claim 1, in which the procedure deselect contains automatic limitation of the duration of a particular medical product to a pre-specified duration.

17. The method according to claim 1, further containing the step of providing to the buyer d is the R warnings and safety measures during the procedure to automatically select and/or deselect.

18. The method according to claim 1, wherein the step of allowing the potential buyer of a medical product to cause the electronic procedure to automatically select and deselect contains the following stages:
give the potential buyer a medical product to cause the electronic procedure to automatically select and deselect via the Internet.

19. The method according to claim 1, additionally containing the following stages:
provide the purchaser the opportunity to buy medical product if the potential purchaser successfully completes a procedure to automatically select or cancel the selection.

20. The method according to claim 19, in which the write operations of purchase and sale contains a proof of purchase of the medical product.

21. The method according to claim 20, further containing the following stages:
show the potential buyer the requirement to submit a record of transactions of sale in the trading terminal.

22. The method according to claim 1, additionally containing the following steps:
require the buyer to get a specific product from a display rack for retail sale; and
show the buyer the requirement to submit a record of transactions of sale and specific product sales employee.

23. A way to market a medical product, the method contains the following steps:
save e -% the fool is automatically selected related to the medical product, in the controller;
retain electronic procedure deselect related to the medical product, in the controller;
give the potential buyer a medical product to cause the electronic procedure to automatically select and deselect by phone;
control the controller via e-automatic procedure of choice to enable the delivery of the medical product to the buyer only if the potential buyer successfully performs the automatic choice for the initial request for the purchase of medical product; and
control the controller via e procedure deselect to enable the delivery of the medical product to the buyer only if the potential purchaser successfully completes the procedure to cancel a selection, for the second or subsequent request for the purchase of medical products.

24. The method according to item 23, in which the medical product contains freely available over-the-counter medical product.

25. The method according to item 23, in which the medical product contains OTC, limited available medical product.

26. The method according to item 23, further containing the step of collecting information from a potential buyer in the part about what edure automatic selection.

27. The method according to item 23, further containing the step of collecting the biometric data characterizing the buyer, potential buyer as part of the procedure of automatic selection.

28. The method according to item 27, further containing the step of analyzing the biometric data characterizing the buyer, as part of the procedure of automatic selection.

29. The method according to item 27 in which the step of collecting the biometric data characterizing the buyer contains the enquiry stage to the potential buyer to manually enter biometric data to the controller.

30. Way of issue of medical products, the method includes the following steps:
identify specific medical product having the status of a limited circulation;
installing a vending machine in a place of total sales, and vending machine contains the device man-machine interface associated with the controller;
keep a stock of a particular medical product in a vending machine;
storing electronic automatic selection controller; and
manage a vending machine by the controller for the grant of the first commercial unit of the particular medical product only if the buyer successfully performs the automatic choice for the initial request for the purchase of specific medical products which act through the device interface.

31. Way of issue of medical product from the vending machine in a place of total sales, and the method comprises the following steps:
acceptat a purchase request from the buyer at the vending machine for a particular medical product with limited appeal;
determine whether the request is for the purchase of the initial request for the purchase or subsequent request for the purchase from the buyer on a particular medical product;
cause the automatic algorithm selection for the particular medical product if a purchase request is the initial request for purchase;
cause the algorithm deselect a specific medicinal product, if a purchase request is a subsequent request for the purchase;
show the buyer the requirement to enter a response to each of the many questions generated by the algorithm to automatically select or algorithm deselect; and
manage a vending machine by automatic algorithm selection or cancellation algorithm of choice to give or not to issue a particular medical product based on the answers.

32. Way of issue of medical product from the vending machine in a place of total sales, and the method comprises the following steps:
acceptat vending machine, a purchase request from a buyer for a particular medical product;
call the live algorithm issuance for the particular medical product;
show the buyer the requirement to enter a response to each of the many questions generated by the algorithm of issuance;
collect biometric data from the customer; and
determine whether to issue or not a particular medical product based on the answers and based at least in part, the biometric data.

33. The method of transfer of prescription medical product in the OTC freely available medical product, with the above-mentioned method contains the following steps:
choose the particular medical product, having the status of a prescription;
develop a set of criteria for the initial issuance of specific medicinal product, and a set of criteria for the initial issuance is sufficient for the responsible regulatory authority has approved the change of status of a particular medical product to OTC status;
develop a set of questions for automatically selecting, focusing on product and customer-centric, based on a set of criteria for the initial issuance;
orderly impose a set of questions for the automatic selection algorithm for automatic selection;
download specific medical product in a vending machine containing the device man-machine interface, electrically connected with the controller;
the mustache is enableval vending machine in a place of total sales;
keep the automatic algorithm selection controller; and
manage a vending machine, via the controller, to produce the first commercial unit of the particular medical product only if the buyer successfully executes the automatic algorithm selection through the device interface.

34. The system of issuing medical product, with the above system contains:
vending machine, limiting the storage location and the storage location is configured to accommodate the at least one medical product limited treatment and at least one medical product unrestricted circulation;
at least one device man-machine interface;
a controller associated with a vending machine and at least one interface device; and
an algorithm for automatic selection, permanently stored in the controller, for each of the medical products limited circulation in the storage location,
moreover, the controller is configured to determine after selecting a specific medical product limited recourse by the buyer via at least one interface device, whether the choice of a particular medical product limited treatment of the first query or the second query for a specific medical prod the CT limited treatment
moreover, the controller is configured to present to the buyer requirements to perform an algorithm for automatic selection, if the request is a first request, and
moreover, the controller configured to issue a specific medical product limited circulation only if the buyer successfully executes the automatic algorithm selection.

35. The translation method is limited available medical product freely available medical product, with the above-mentioned method contains the following steps:
choose the particular medical product, having the status of limited available;
develop a set of criteria for the initial issuance of specific medicinal product, and a set of criteria for the initial issuance is sufficient for the responsible regulatory authority has approved the change of status of a particular medical product status freely available;
develop a set of questions for automatically selecting, focusing on product and customer-centric, based on a set of criteria for the initial issuance;
orderly impose a set of questions for the automatic selection algorithm for automatic selection;
download specific medical product in a vending machine containing the device man-machine interf is ISA, electrically connected with the controller;
installing a vending machine in a place of total sales;
keep the automatic algorithm selection controller; and
manage a vending machine, via the controller, to produce the first commercial unit of the particular medical product only if the buyer successfully executes the automatic algorithm selection through the device interface.

36. The technique of marketing a particular medical product, with the above-mentioned method contains the following steps:
provide the controller that contains the selection algorithm is constantly stored in the controller for the particular medical product;
provide the purchaser the opportunity to call the algorithm selection;
control algorithm selection to provide to the buyer a multitude of exemplary symptoms or disease cases for a particular medical product through at least one input device and communication;
provide the purchaser the opportunity to choose at least one symptom or condition of a disease from a variety of exemplary symptoms or disease States, when at least one symptom of a condition or disease consistent with those currently experienced by the buyer; and
determine the request for the purchase of the initial request p is the Kupka or subsequent request for the purchase from the buyer on a particular medical product;
cause the automatic algorithm selection for the particular medical product if a purchase request is the initial request for purchase;
cause the algorithm deselect a specific medicinal product, if a purchase request is a subsequent request for the purchase;
show the buyer the requirement to enter a response to each of the many questions generated by the algorithm for automatic selection or cancellation algorithm selection; and
provide with an algorithm to automatically select or algorithm deselect the purchaser the opportunity to buy the particular medical product based on the answers.